Global Intranasal Vaccine Market Growth 2026-2032
The global Intranasal Vaccine market size is predicted to grow from US$ 636 million in 2025 to US$ 900 million in 2032; it is expected to grow at a CAGR of 5.2% from 2026 to 2032.
Vaccines administered nasally
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LP Information, Inc. (LPI) ' newest research report, the ?Intranasal Vaccine Industry Forecast? looks at past sales and reviews total world Intranasal Vaccine sales in 2025, providing a comprehensive analysis by region and market sector of projected Intranasal Vaccine sales for 2026 through 2032. With Intranasal Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Intranasal Vaccine industry.
This Insight Report provides a comprehensive analysis of the global Intranasal Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Intranasal Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Intranasal Vaccine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Intranasal Vaccine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Intranasal Vaccine.
This report presents a comprehensive overview, market shares, and growth opportunities of Intranasal Vaccine market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Vaccines administered nasally
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LP Information, Inc. (LPI) ' newest research report, the ?Intranasal Vaccine Industry Forecast? looks at past sales and reviews total world Intranasal Vaccine sales in 2025, providing a comprehensive analysis by region and market sector of projected Intranasal Vaccine sales for 2026 through 2032. With Intranasal Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Intranasal Vaccine industry.
This Insight Report provides a comprehensive analysis of the global Intranasal Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Intranasal Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Intranasal Vaccine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Intranasal Vaccine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Intranasal Vaccine.
This report presents a comprehensive overview, market shares, and growth opportunities of Intranasal Vaccine market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Flu Vaccine
- COVID-19 Vaccines
- Hospital
- Clinic
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Sanofi
- AstraZeneca
- Abbott
- GlaxoSmithKline
- Serum Institute of India
- Bharat Biotech
- Antares Pharma
- INJEX Pharma GmbH
- BioDiem
- PharmaJet and Crossject
- Beijing Wantai Biopharmaceutical Co., Ltd.
- Changchun Baike Company
- What is the 10-year outlook for the global Intranasal Vaccine market?
- What factors are driving Intranasal Vaccine market growth, globally and by region?
- Which technologies are poised for the fastest growth by market and region?
- How do Intranasal Vaccine market opportunities vary by end market size?
- How does Intranasal Vaccine break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Intranasal Vaccine Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Intranasal Vaccine by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Intranasal Vaccine by Country/Region, 2021, 2025 & 2032
2.2 Intranasal Vaccine Segment by Type
2.2.1 Flu Vaccine
2.2.2 COVID-19 Vaccines
2.2.3 Intranasal Vaccine Sales by Type
2.2.3.1 Global Intranasal Vaccine Sales Market Share by Type (2021-2026)
2.2.3.2 Global Intranasal Vaccine Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Intranasal Vaccine Sale Price by Type (2021-2026)
2.3 Intranasal Vaccine Segment by Application
2.3.1 Hospital
2.3.2 Clinic
2.3.3 Intranasal Vaccine Sales by Application
2.3.3.1 Global Intranasal Vaccine Sale Market Share by Application (2021-2026)
2.3.3.2 Global Intranasal Vaccine Revenue and Market Share by Application (2021-2026)
2.3.3.3 Global Intranasal Vaccine Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Intranasal Vaccine Breakdown Data by Company
3.1.1 Global Intranasal Vaccine Annual Sales by Company (2021-2026)
3.1.2 Global Intranasal Vaccine Sales Market Share by Company (2021-2026)
3.2 Global Intranasal Vaccine Annual Revenue by Company (2021-2026)
3.2.1 Global Intranasal Vaccine Revenue by Company (2021-2026)
3.2.2 Global Intranasal Vaccine Revenue Market Share by Company (2021-2026)
3.3 Global Intranasal Vaccine Sale Price by Company
3.4 Key Manufacturers Intranasal Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Intranasal Vaccine Product Location Distribution
3.4.2 Players Intranasal Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR INTRANASAL VACCINE BY GEOGRAPHIC REGION
4.1 World Historic Intranasal Vaccine Market Size by Geographic Region (2021-2026)
4.1.1 Global Intranasal Vaccine Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Intranasal Vaccine Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Intranasal Vaccine Market Size by Country/Region (2021-2026)
4.2.1 Global Intranasal Vaccine Annual Sales by Country/Region (2021-2026)
4.2.2 Global Intranasal Vaccine Annual Revenue by Country/Region (2021-2026)
4.3 Americas Intranasal Vaccine Sales Growth
4.4 APAC Intranasal Vaccine Sales Growth
4.5 Europe Intranasal Vaccine Sales Growth
4.6 Middle East & Africa Intranasal Vaccine Sales Growth
5 AMERICAS
5.1 Americas Intranasal Vaccine Sales by Country
5.1.1 Americas Intranasal Vaccine Sales by Country (2021-2026)
5.1.2 Americas Intranasal Vaccine Revenue by Country (2021-2026)
5.2 Americas Intranasal Vaccine Sales by Type (2021-2026)
5.3 Americas Intranasal Vaccine Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Intranasal Vaccine Sales by Region
6.1.1 APAC Intranasal Vaccine Sales by Region (2021-2026)
6.1.2 APAC Intranasal Vaccine Revenue by Region (2021-2026)
6.2 APAC Intranasal Vaccine Sales by Type (2021-2026)
6.3 APAC Intranasal Vaccine Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Intranasal Vaccine by Country
7.1.1 Europe Intranasal Vaccine Sales by Country (2021-2026)
7.1.2 Europe Intranasal Vaccine Revenue by Country (2021-2026)
7.2 Europe Intranasal Vaccine Sales by Type (2021-2026)
7.3 Europe Intranasal Vaccine Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Intranasal Vaccine by Country
8.1.1 Middle East & Africa Intranasal Vaccine Sales by Country (2021-2026)
8.1.2 Middle East & Africa Intranasal Vaccine Revenue by Country (2021-2026)
8.2 Middle East & Africa Intranasal Vaccine Sales by Type (2021-2026)
8.3 Middle East & Africa Intranasal Vaccine Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Intranasal Vaccine
10.3 Manufacturing Process Analysis of Intranasal Vaccine
10.4 Industry Chain Structure of Intranasal Vaccine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Intranasal Vaccine Distributors
11.3 Intranasal Vaccine Customer
12 WORLD FORECAST REVIEW FOR INTRANASAL VACCINE BY GEOGRAPHIC REGION
12.1 Global Intranasal Vaccine Market Size Forecast by Region
12.1.1 Global Intranasal Vaccine Forecast by Region (2027-2032)
12.1.2 Global Intranasal Vaccine Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Intranasal Vaccine Forecast by Type (2027-2032)
12.7 Global Intranasal Vaccine Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Sanofi
13.1.1 Sanofi Company Information
13.1.2 Sanofi Intranasal Vaccine Product Portfolios and Specifications
13.1.3 Sanofi Intranasal Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Sanofi Main Business Overview
13.1.5 Sanofi Latest Developments
13.2 AstraZeneca
13.2.1 AstraZeneca Company Information
13.2.2 AstraZeneca Intranasal Vaccine Product Portfolios and Specifications
13.2.3 AstraZeneca Intranasal Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 AstraZeneca Main Business Overview
13.2.5 AstraZeneca Latest Developments
13.3 Abbott
13.3.1 Abbott Company Information
13.3.2 Abbott Intranasal Vaccine Product Portfolios and Specifications
13.3.3 Abbott Intranasal Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Abbott Main Business Overview
13.3.5 Abbott Latest Developments
13.4 GlaxoSmithKline
13.4.1 GlaxoSmithKline Company Information
13.4.2 GlaxoSmithKline Intranasal Vaccine Product Portfolios and Specifications
13.4.3 GlaxoSmithKline Intranasal Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 GlaxoSmithKline Main Business Overview
13.4.5 GlaxoSmithKline Latest Developments
13.5 Serum Institute of India
13.5.1 Serum Institute of India Company Information
13.5.2 Serum Institute of India Intranasal Vaccine Product Portfolios and Specifications
13.5.3 Serum Institute of India Intranasal Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Serum Institute of India Main Business Overview
13.5.5 Serum Institute of India Latest Developments
13.6 Bharat Biotech
13.6.1 Bharat Biotech Company Information
13.6.2 Bharat Biotech Intranasal Vaccine Product Portfolios and Specifications
13.6.3 Bharat Biotech Intranasal Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Bharat Biotech Main Business Overview
13.6.5 Bharat Biotech Latest Developments
13.7 Antares Pharma
13.7.1 Antares Pharma Company Information
13.7.2 Antares Pharma Intranasal Vaccine Product Portfolios and Specifications
13.7.3 Antares Pharma Intranasal Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Antares Pharma Main Business Overview
13.7.5 Antares Pharma Latest Developments
13.8 INJEX Pharma GmbH
13.8.1 INJEX Pharma GmbH Company Information
13.8.2 INJEX Pharma GmbH Intranasal Vaccine Product Portfolios and Specifications
13.8.3 INJEX Pharma GmbH Intranasal Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 INJEX Pharma GmbH Main Business Overview
13.8.5 INJEX Pharma GmbH Latest Developments
13.9 BioDiem
13.9.1 BioDiem Company Information
13.9.2 BioDiem Intranasal Vaccine Product Portfolios and Specifications
13.9.3 BioDiem Intranasal Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 BioDiem Main Business Overview
13.9.5 BioDiem Latest Developments
13.10 PharmaJet and Crossject
13.10.1 PharmaJet and Crossject Company Information
13.10.2 PharmaJet and Crossject Intranasal Vaccine Product Portfolios and Specifications
13.10.3 PharmaJet and Crossject Intranasal Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 PharmaJet and Crossject Main Business Overview
13.10.5 PharmaJet and Crossject Latest Developments
13.11 Beijing Wantai Biopharmaceutical Co., Ltd.
13.11.1 Beijing Wantai Biopharmaceutical Co., Ltd. Company Information
13.11.2 Beijing Wantai Biopharmaceutical Co., Ltd. Intranasal Vaccine Product Portfolios and Specifications
13.11.3 Beijing Wantai Biopharmaceutical Co., Ltd. Intranasal Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Beijing Wantai Biopharmaceutical Co., Ltd. Main Business Overview
13.11.5 Beijing Wantai Biopharmaceutical Co., Ltd. Latest Developments
13.12 Changchun Baike Company
13.12.1 Changchun Baike Company Company Information
13.12.2 Changchun Baike Company Intranasal Vaccine Product Portfolios and Specifications
13.12.3 Changchun Baike Company Intranasal Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Changchun Baike Company Main Business Overview
13.12.5 Changchun Baike Company Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Intranasal Vaccine Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Intranasal Vaccine by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Intranasal Vaccine by Country/Region, 2021, 2025 & 2032
2.2 Intranasal Vaccine Segment by Type
2.2.1 Flu Vaccine
2.2.2 COVID-19 Vaccines
2.2.3 Intranasal Vaccine Sales by Type
2.2.3.1 Global Intranasal Vaccine Sales Market Share by Type (2021-2026)
2.2.3.2 Global Intranasal Vaccine Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Intranasal Vaccine Sale Price by Type (2021-2026)
2.3 Intranasal Vaccine Segment by Application
2.3.1 Hospital
2.3.2 Clinic
2.3.3 Intranasal Vaccine Sales by Application
2.3.3.1 Global Intranasal Vaccine Sale Market Share by Application (2021-2026)
2.3.3.2 Global Intranasal Vaccine Revenue and Market Share by Application (2021-2026)
2.3.3.3 Global Intranasal Vaccine Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Intranasal Vaccine Breakdown Data by Company
3.1.1 Global Intranasal Vaccine Annual Sales by Company (2021-2026)
3.1.2 Global Intranasal Vaccine Sales Market Share by Company (2021-2026)
3.2 Global Intranasal Vaccine Annual Revenue by Company (2021-2026)
3.2.1 Global Intranasal Vaccine Revenue by Company (2021-2026)
3.2.2 Global Intranasal Vaccine Revenue Market Share by Company (2021-2026)
3.3 Global Intranasal Vaccine Sale Price by Company
3.4 Key Manufacturers Intranasal Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Intranasal Vaccine Product Location Distribution
3.4.2 Players Intranasal Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR INTRANASAL VACCINE BY GEOGRAPHIC REGION
4.1 World Historic Intranasal Vaccine Market Size by Geographic Region (2021-2026)
4.1.1 Global Intranasal Vaccine Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Intranasal Vaccine Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Intranasal Vaccine Market Size by Country/Region (2021-2026)
4.2.1 Global Intranasal Vaccine Annual Sales by Country/Region (2021-2026)
4.2.2 Global Intranasal Vaccine Annual Revenue by Country/Region (2021-2026)
4.3 Americas Intranasal Vaccine Sales Growth
4.4 APAC Intranasal Vaccine Sales Growth
4.5 Europe Intranasal Vaccine Sales Growth
4.6 Middle East & Africa Intranasal Vaccine Sales Growth
5 AMERICAS
5.1 Americas Intranasal Vaccine Sales by Country
5.1.1 Americas Intranasal Vaccine Sales by Country (2021-2026)
5.1.2 Americas Intranasal Vaccine Revenue by Country (2021-2026)
5.2 Americas Intranasal Vaccine Sales by Type (2021-2026)
5.3 Americas Intranasal Vaccine Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Intranasal Vaccine Sales by Region
6.1.1 APAC Intranasal Vaccine Sales by Region (2021-2026)
6.1.2 APAC Intranasal Vaccine Revenue by Region (2021-2026)
6.2 APAC Intranasal Vaccine Sales by Type (2021-2026)
6.3 APAC Intranasal Vaccine Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Intranasal Vaccine by Country
7.1.1 Europe Intranasal Vaccine Sales by Country (2021-2026)
7.1.2 Europe Intranasal Vaccine Revenue by Country (2021-2026)
7.2 Europe Intranasal Vaccine Sales by Type (2021-2026)
7.3 Europe Intranasal Vaccine Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Intranasal Vaccine by Country
8.1.1 Middle East & Africa Intranasal Vaccine Sales by Country (2021-2026)
8.1.2 Middle East & Africa Intranasal Vaccine Revenue by Country (2021-2026)
8.2 Middle East & Africa Intranasal Vaccine Sales by Type (2021-2026)
8.3 Middle East & Africa Intranasal Vaccine Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Intranasal Vaccine
10.3 Manufacturing Process Analysis of Intranasal Vaccine
10.4 Industry Chain Structure of Intranasal Vaccine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Intranasal Vaccine Distributors
11.3 Intranasal Vaccine Customer
12 WORLD FORECAST REVIEW FOR INTRANASAL VACCINE BY GEOGRAPHIC REGION
12.1 Global Intranasal Vaccine Market Size Forecast by Region
12.1.1 Global Intranasal Vaccine Forecast by Region (2027-2032)
12.1.2 Global Intranasal Vaccine Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Intranasal Vaccine Forecast by Type (2027-2032)
12.7 Global Intranasal Vaccine Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Sanofi
13.1.1 Sanofi Company Information
13.1.2 Sanofi Intranasal Vaccine Product Portfolios and Specifications
13.1.3 Sanofi Intranasal Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Sanofi Main Business Overview
13.1.5 Sanofi Latest Developments
13.2 AstraZeneca
13.2.1 AstraZeneca Company Information
13.2.2 AstraZeneca Intranasal Vaccine Product Portfolios and Specifications
13.2.3 AstraZeneca Intranasal Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 AstraZeneca Main Business Overview
13.2.5 AstraZeneca Latest Developments
13.3 Abbott
13.3.1 Abbott Company Information
13.3.2 Abbott Intranasal Vaccine Product Portfolios and Specifications
13.3.3 Abbott Intranasal Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Abbott Main Business Overview
13.3.5 Abbott Latest Developments
13.4 GlaxoSmithKline
13.4.1 GlaxoSmithKline Company Information
13.4.2 GlaxoSmithKline Intranasal Vaccine Product Portfolios and Specifications
13.4.3 GlaxoSmithKline Intranasal Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 GlaxoSmithKline Main Business Overview
13.4.5 GlaxoSmithKline Latest Developments
13.5 Serum Institute of India
13.5.1 Serum Institute of India Company Information
13.5.2 Serum Institute of India Intranasal Vaccine Product Portfolios and Specifications
13.5.3 Serum Institute of India Intranasal Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Serum Institute of India Main Business Overview
13.5.5 Serum Institute of India Latest Developments
13.6 Bharat Biotech
13.6.1 Bharat Biotech Company Information
13.6.2 Bharat Biotech Intranasal Vaccine Product Portfolios and Specifications
13.6.3 Bharat Biotech Intranasal Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Bharat Biotech Main Business Overview
13.6.5 Bharat Biotech Latest Developments
13.7 Antares Pharma
13.7.1 Antares Pharma Company Information
13.7.2 Antares Pharma Intranasal Vaccine Product Portfolios and Specifications
13.7.3 Antares Pharma Intranasal Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Antares Pharma Main Business Overview
13.7.5 Antares Pharma Latest Developments
13.8 INJEX Pharma GmbH
13.8.1 INJEX Pharma GmbH Company Information
13.8.2 INJEX Pharma GmbH Intranasal Vaccine Product Portfolios and Specifications
13.8.3 INJEX Pharma GmbH Intranasal Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 INJEX Pharma GmbH Main Business Overview
13.8.5 INJEX Pharma GmbH Latest Developments
13.9 BioDiem
13.9.1 BioDiem Company Information
13.9.2 BioDiem Intranasal Vaccine Product Portfolios and Specifications
13.9.3 BioDiem Intranasal Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 BioDiem Main Business Overview
13.9.5 BioDiem Latest Developments
13.10 PharmaJet and Crossject
13.10.1 PharmaJet and Crossject Company Information
13.10.2 PharmaJet and Crossject Intranasal Vaccine Product Portfolios and Specifications
13.10.3 PharmaJet and Crossject Intranasal Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 PharmaJet and Crossject Main Business Overview
13.10.5 PharmaJet and Crossject Latest Developments
13.11 Beijing Wantai Biopharmaceutical Co., Ltd.
13.11.1 Beijing Wantai Biopharmaceutical Co., Ltd. Company Information
13.11.2 Beijing Wantai Biopharmaceutical Co., Ltd. Intranasal Vaccine Product Portfolios and Specifications
13.11.3 Beijing Wantai Biopharmaceutical Co., Ltd. Intranasal Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Beijing Wantai Biopharmaceutical Co., Ltd. Main Business Overview
13.11.5 Beijing Wantai Biopharmaceutical Co., Ltd. Latest Developments
13.12 Changchun Baike Company
13.12.1 Changchun Baike Company Company Information
13.12.2 Changchun Baike Company Intranasal Vaccine Product Portfolios and Specifications
13.12.3 Changchun Baike Company Intranasal Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Changchun Baike Company Main Business Overview
13.12.5 Changchun Baike Company Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Intranasal Vaccine Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Intranasal Vaccine Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Flu Vaccine
Table 4. Major Players of COVID-19 Vaccines
Table 5. Global Intranasal Vaccine Sales by Type (2021-2026) & (K Units)
Table 6. Global Intranasal Vaccine Sales Market Share by Type (2021-2026)
Table 7. Global Intranasal Vaccine Revenue by Type (2021-2026) & ($ million)
Table 8. Global Intranasal Vaccine Revenue Market Share by Type (2021-2026)
Table 9. Global Intranasal Vaccine Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Global Intranasal Vaccine Sale by Application (2021-2026) & (K Units)
Table 11. Global Intranasal Vaccine Sale Market Share by Application (2021-2026)
Table 12. Global Intranasal Vaccine Revenue by Application (2021-2026) & ($ million)
Table 13. Global Intranasal Vaccine Revenue Market Share by Application (2021-2026)
Table 14. Global Intranasal Vaccine Sale Price by Application (2021-2026) & (US$/Unit)
Table 15. Global Intranasal Vaccine Sales by Company (2021-2026) & (K Units)
Table 16. Global Intranasal Vaccine Sales Market Share by Company (2021-2026)
Table 17. Global Intranasal Vaccine Revenue by Company (2021-2026) & ($ millions)
Table 18. Global Intranasal Vaccine Revenue Market Share by Company (2021-2026)
Table 19. Global Intranasal Vaccine Sale Price by Company (2021-2026) & (US$/Unit)
Table 20. Key Manufacturers Intranasal Vaccine Producing Area Distribution and Sales Area
Table 21. Players Intranasal Vaccine Products Offered
Table 22. Intranasal Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Intranasal Vaccine Sales by Geographic Region (2021-2026) & (K Units)
Table 26. Global Intranasal Vaccine Sales Market Share Geographic Region (2021-2026)
Table 27. Global Intranasal Vaccine Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global Intranasal Vaccine Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global Intranasal Vaccine Sales by Country/Region (2021-2026) & (K Units)
Table 30. Global Intranasal Vaccine Sales Market Share by Country/Region (2021-2026)
Table 31. Global Intranasal Vaccine Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global Intranasal Vaccine Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas Intranasal Vaccine Sales by Country (2021-2026) & (K Units)
Table 34. Americas Intranasal Vaccine Sales Market Share by Country (2021-2026)
Table 35. Americas Intranasal Vaccine Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas Intranasal Vaccine Sales by Type (2021-2026) & (K Units)
Table 37. Americas Intranasal Vaccine Sales by Application (2021-2026) & (K Units)
Table 38. APAC Intranasal Vaccine Sales by Region (2021-2026) & (K Units)
Table 39. APAC Intranasal Vaccine Sales Market Share by Region (2021-2026)
Table 40. APAC Intranasal Vaccine Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC Intranasal Vaccine Sales by Type (2021-2026) & (K Units)
Table 42. APAC Intranasal Vaccine Sales by Application (2021-2026) & (K Units)
Table 43. Europe Intranasal Vaccine Sales by Country (2021-2026) & (K Units)
Table 44. Europe Intranasal Vaccine Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe Intranasal Vaccine Sales by Type (2021-2026) & (K Units)
Table 46. Europe Intranasal Vaccine Sales by Application (2021-2026) & (K Units)
Table 47. Middle East & Africa Intranasal Vaccine Sales by Country (2021-2026) & (K Units)
Table 48. Middle East & Africa Intranasal Vaccine Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa Intranasal Vaccine Sales by Type (2021-2026) & (K Units)
Table 50. Middle East & Africa Intranasal Vaccine Sales by Application (2021-2026) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Intranasal Vaccine
Table 52. Key Market Challenges & Risks of Intranasal Vaccine
Table 53. Key Industry Trends of Intranasal Vaccine
Table 54. Intranasal Vaccine Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Intranasal Vaccine Distributors List
Table 57. Intranasal Vaccine Customer List
Table 58. Global Intranasal Vaccine Sales Forecast by Region (2027-2032) & (K Units)
Table 59. Global Intranasal Vaccine Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas Intranasal Vaccine Sales Forecast by Country (2027-2032) & (K Units)
Table 61. Americas Intranasal Vaccine Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC Intranasal Vaccine Sales Forecast by Region (2027-2032) & (K Units)
Table 63. APAC Intranasal Vaccine Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe Intranasal Vaccine Sales Forecast by Country (2027-2032) & (K Units)
Table 65. Europe Intranasal Vaccine Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa Intranasal Vaccine Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Middle East & Africa Intranasal Vaccine Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global Intranasal Vaccine Sales Forecast by Type (2027-2032) & (K Units)
Table 69. Global Intranasal Vaccine Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global Intranasal Vaccine Sales Forecast by Application (2027-2032) & (K Units)
Table 71. Global Intranasal Vaccine Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. Sanofi Basic Information, Intranasal Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 73. Sanofi Intranasal Vaccine Product Portfolios and Specifications
Table 74. Sanofi Intranasal Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 75. Sanofi Main Business
Table 76. Sanofi Latest Developments
Table 77. AstraZeneca Basic Information, Intranasal Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 78. AstraZeneca Intranasal Vaccine Product Portfolios and Specifications
Table 79. AstraZeneca Intranasal Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. AstraZeneca Main Business
Table 81. AstraZeneca Latest Developments
Table 82. Abbott Basic Information, Intranasal Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 83. Abbott Intranasal Vaccine Product Portfolios and Specifications
Table 84. Abbott Intranasal Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 85. Abbott Main Business
Table 86. Abbott Latest Developments
Table 87. GlaxoSmithKline Basic Information, Intranasal Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 88. GlaxoSmithKline Intranasal Vaccine Product Portfolios and Specifications
Table 89. GlaxoSmithKline Intranasal Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. GlaxoSmithKline Main Business
Table 91. GlaxoSmithKline Latest Developments
Table 92. Serum Institute of India Basic Information, Intranasal Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 93. Serum Institute of India Intranasal Vaccine Product Portfolios and Specifications
Table 94. Serum Institute of India Intranasal Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. Serum Institute of India Main Business
Table 96. Serum Institute of India Latest Developments
Table 97. Bharat Biotech Basic Information, Intranasal Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 98. Bharat Biotech Intranasal Vaccine Product Portfolios and Specifications
Table 99. Bharat Biotech Intranasal Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 100. Bharat Biotech Main Business
Table 101. Bharat Biotech Latest Developments
Table 102. Antares Pharma Basic Information, Intranasal Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 103. Antares Pharma Intranasal Vaccine Product Portfolios and Specifications
Table 104. Antares Pharma Intranasal Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 105. Antares Pharma Main Business
Table 106. Antares Pharma Latest Developments
Table 107. INJEX Pharma GmbH Basic Information, Intranasal Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 108. INJEX Pharma GmbH Intranasal Vaccine Product Portfolios and Specifications
Table 109. INJEX Pharma GmbH Intranasal Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 110. INJEX Pharma GmbH Main Business
Table 111. INJEX Pharma GmbH Latest Developments
Table 112. BioDiem Basic Information, Intranasal Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 113. BioDiem Intranasal Vaccine Product Portfolios and Specifications
Table 114. BioDiem Intranasal Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 115. BioDiem Main Business
Table 116. BioDiem Latest Developments
Table 117. PharmaJet and Crossject Basic Information, Intranasal Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 118. PharmaJet and Crossject Intranasal Vaccine Product Portfolios and Specifications
Table 119. PharmaJet and Crossject Intranasal Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 120. PharmaJet and Crossject Main Business
Table 121. PharmaJet and Crossject Latest Developments
Table 122. Beijing Wantai Biopharmaceutical Co., Ltd. Basic Information, Intranasal Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 123. Beijing Wantai Biopharmaceutical Co., Ltd. Intranasal Vaccine Product Portfolios and Specifications
Table 124. Beijing Wantai Biopharmaceutical Co., Ltd. Intranasal Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 125. Beijing Wantai Biopharmaceutical Co., Ltd. Main Business
Table 126. Beijing Wantai Biopharmaceutical Co., Ltd. Latest Developments
Table 127. Changchun Baike Company Basic Information, Intranasal Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 128. Changchun Baike Company Intranasal Vaccine Product Portfolios and Specifications
Table 129. Changchun Baike Company Intranasal Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 130. Changchun Baike Company Main Business
Table 131. Changchun Baike Company Latest Developments
Table 1. Intranasal Vaccine Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Intranasal Vaccine Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Flu Vaccine
Table 4. Major Players of COVID-19 Vaccines
Table 5. Global Intranasal Vaccine Sales by Type (2021-2026) & (K Units)
Table 6. Global Intranasal Vaccine Sales Market Share by Type (2021-2026)
Table 7. Global Intranasal Vaccine Revenue by Type (2021-2026) & ($ million)
Table 8. Global Intranasal Vaccine Revenue Market Share by Type (2021-2026)
Table 9. Global Intranasal Vaccine Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Global Intranasal Vaccine Sale by Application (2021-2026) & (K Units)
Table 11. Global Intranasal Vaccine Sale Market Share by Application (2021-2026)
Table 12. Global Intranasal Vaccine Revenue by Application (2021-2026) & ($ million)
Table 13. Global Intranasal Vaccine Revenue Market Share by Application (2021-2026)
Table 14. Global Intranasal Vaccine Sale Price by Application (2021-2026) & (US$/Unit)
Table 15. Global Intranasal Vaccine Sales by Company (2021-2026) & (K Units)
Table 16. Global Intranasal Vaccine Sales Market Share by Company (2021-2026)
Table 17. Global Intranasal Vaccine Revenue by Company (2021-2026) & ($ millions)
Table 18. Global Intranasal Vaccine Revenue Market Share by Company (2021-2026)
Table 19. Global Intranasal Vaccine Sale Price by Company (2021-2026) & (US$/Unit)
Table 20. Key Manufacturers Intranasal Vaccine Producing Area Distribution and Sales Area
Table 21. Players Intranasal Vaccine Products Offered
Table 22. Intranasal Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Intranasal Vaccine Sales by Geographic Region (2021-2026) & (K Units)
Table 26. Global Intranasal Vaccine Sales Market Share Geographic Region (2021-2026)
Table 27. Global Intranasal Vaccine Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global Intranasal Vaccine Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global Intranasal Vaccine Sales by Country/Region (2021-2026) & (K Units)
Table 30. Global Intranasal Vaccine Sales Market Share by Country/Region (2021-2026)
Table 31. Global Intranasal Vaccine Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global Intranasal Vaccine Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas Intranasal Vaccine Sales by Country (2021-2026) & (K Units)
Table 34. Americas Intranasal Vaccine Sales Market Share by Country (2021-2026)
Table 35. Americas Intranasal Vaccine Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas Intranasal Vaccine Sales by Type (2021-2026) & (K Units)
Table 37. Americas Intranasal Vaccine Sales by Application (2021-2026) & (K Units)
Table 38. APAC Intranasal Vaccine Sales by Region (2021-2026) & (K Units)
Table 39. APAC Intranasal Vaccine Sales Market Share by Region (2021-2026)
Table 40. APAC Intranasal Vaccine Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC Intranasal Vaccine Sales by Type (2021-2026) & (K Units)
Table 42. APAC Intranasal Vaccine Sales by Application (2021-2026) & (K Units)
Table 43. Europe Intranasal Vaccine Sales by Country (2021-2026) & (K Units)
Table 44. Europe Intranasal Vaccine Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe Intranasal Vaccine Sales by Type (2021-2026) & (K Units)
Table 46. Europe Intranasal Vaccine Sales by Application (2021-2026) & (K Units)
Table 47. Middle East & Africa Intranasal Vaccine Sales by Country (2021-2026) & (K Units)
Table 48. Middle East & Africa Intranasal Vaccine Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa Intranasal Vaccine Sales by Type (2021-2026) & (K Units)
Table 50. Middle East & Africa Intranasal Vaccine Sales by Application (2021-2026) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Intranasal Vaccine
Table 52. Key Market Challenges & Risks of Intranasal Vaccine
Table 53. Key Industry Trends of Intranasal Vaccine
Table 54. Intranasal Vaccine Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Intranasal Vaccine Distributors List
Table 57. Intranasal Vaccine Customer List
Table 58. Global Intranasal Vaccine Sales Forecast by Region (2027-2032) & (K Units)
Table 59. Global Intranasal Vaccine Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas Intranasal Vaccine Sales Forecast by Country (2027-2032) & (K Units)
Table 61. Americas Intranasal Vaccine Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC Intranasal Vaccine Sales Forecast by Region (2027-2032) & (K Units)
Table 63. APAC Intranasal Vaccine Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe Intranasal Vaccine Sales Forecast by Country (2027-2032) & (K Units)
Table 65. Europe Intranasal Vaccine Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa Intranasal Vaccine Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Middle East & Africa Intranasal Vaccine Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global Intranasal Vaccine Sales Forecast by Type (2027-2032) & (K Units)
Table 69. Global Intranasal Vaccine Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global Intranasal Vaccine Sales Forecast by Application (2027-2032) & (K Units)
Table 71. Global Intranasal Vaccine Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. Sanofi Basic Information, Intranasal Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 73. Sanofi Intranasal Vaccine Product Portfolios and Specifications
Table 74. Sanofi Intranasal Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 75. Sanofi Main Business
Table 76. Sanofi Latest Developments
Table 77. AstraZeneca Basic Information, Intranasal Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 78. AstraZeneca Intranasal Vaccine Product Portfolios and Specifications
Table 79. AstraZeneca Intranasal Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. AstraZeneca Main Business
Table 81. AstraZeneca Latest Developments
Table 82. Abbott Basic Information, Intranasal Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 83. Abbott Intranasal Vaccine Product Portfolios and Specifications
Table 84. Abbott Intranasal Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 85. Abbott Main Business
Table 86. Abbott Latest Developments
Table 87. GlaxoSmithKline Basic Information, Intranasal Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 88. GlaxoSmithKline Intranasal Vaccine Product Portfolios and Specifications
Table 89. GlaxoSmithKline Intranasal Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. GlaxoSmithKline Main Business
Table 91. GlaxoSmithKline Latest Developments
Table 92. Serum Institute of India Basic Information, Intranasal Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 93. Serum Institute of India Intranasal Vaccine Product Portfolios and Specifications
Table 94. Serum Institute of India Intranasal Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. Serum Institute of India Main Business
Table 96. Serum Institute of India Latest Developments
Table 97. Bharat Biotech Basic Information, Intranasal Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 98. Bharat Biotech Intranasal Vaccine Product Portfolios and Specifications
Table 99. Bharat Biotech Intranasal Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 100. Bharat Biotech Main Business
Table 101. Bharat Biotech Latest Developments
Table 102. Antares Pharma Basic Information, Intranasal Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 103. Antares Pharma Intranasal Vaccine Product Portfolios and Specifications
Table 104. Antares Pharma Intranasal Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 105. Antares Pharma Main Business
Table 106. Antares Pharma Latest Developments
Table 107. INJEX Pharma GmbH Basic Information, Intranasal Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 108. INJEX Pharma GmbH Intranasal Vaccine Product Portfolios and Specifications
Table 109. INJEX Pharma GmbH Intranasal Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 110. INJEX Pharma GmbH Main Business
Table 111. INJEX Pharma GmbH Latest Developments
Table 112. BioDiem Basic Information, Intranasal Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 113. BioDiem Intranasal Vaccine Product Portfolios and Specifications
Table 114. BioDiem Intranasal Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 115. BioDiem Main Business
Table 116. BioDiem Latest Developments
Table 117. PharmaJet and Crossject Basic Information, Intranasal Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 118. PharmaJet and Crossject Intranasal Vaccine Product Portfolios and Specifications
Table 119. PharmaJet and Crossject Intranasal Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 120. PharmaJet and Crossject Main Business
Table 121. PharmaJet and Crossject Latest Developments
Table 122. Beijing Wantai Biopharmaceutical Co., Ltd. Basic Information, Intranasal Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 123. Beijing Wantai Biopharmaceutical Co., Ltd. Intranasal Vaccine Product Portfolios and Specifications
Table 124. Beijing Wantai Biopharmaceutical Co., Ltd. Intranasal Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 125. Beijing Wantai Biopharmaceutical Co., Ltd. Main Business
Table 126. Beijing Wantai Biopharmaceutical Co., Ltd. Latest Developments
Table 127. Changchun Baike Company Basic Information, Intranasal Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 128. Changchun Baike Company Intranasal Vaccine Product Portfolios and Specifications
Table 129. Changchun Baike Company Intranasal Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 130. Changchun Baike Company Main Business
Table 131. Changchun Baike Company Latest Developments
LIST OF FIGURES
Figure 1. Picture of Intranasal Vaccine
Figure 2. Intranasal Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Intranasal Vaccine Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Intranasal Vaccine Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Intranasal Vaccine Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Intranasal Vaccine Sales Market Share by Country/Region (2025)
Figure 10. Intranasal Vaccine Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Flu Vaccine
Figure 12. Product Picture of COVID-19 Vaccines
Figure 13. Global Intranasal Vaccine Sales Market Share by Type in 2026
Figure 14. Global Intranasal Vaccine Revenue Market Share by Type (2021-2026)
Figure 15. Intranasal Vaccine Consumed in Hospital
Figure 16. Global Intranasal Vaccine Market: Hospital (2021-2026) & (K Units)
Figure 17. Intranasal Vaccine Consumed in Clinic
Figure 18. Global Intranasal Vaccine Market: Clinic (2021-2026) & (K Units)
Figure 19. Global Intranasal Vaccine Sale Market Share by Application (2025)
Figure 20. Global Intranasal Vaccine Revenue Market Share by Application in 2026
Figure 21. Intranasal Vaccine Sales by Company in 2026 (K Units)
Figure 22. Global Intranasal Vaccine Sales Market Share by Company in 2026
Figure 23. Intranasal Vaccine Revenue by Company in 2026 ($ millions)
Figure 24. Global Intranasal Vaccine Revenue Market Share by Company in 2026
Figure 25. Global Intranasal Vaccine Sales Market Share by Geographic Region (2021-2026)
Figure 26. Global Intranasal Vaccine Revenue Market Share by Geographic Region in 2026
Figure 27. Americas Intranasal Vaccine Sales 2021-2026 (K Units)
Figure 28. Americas Intranasal Vaccine Revenue 2021-2026 ($ millions)
Figure 29. APAC Intranasal Vaccine Sales 2021-2026 (K Units)
Figure 30. APAC Intranasal Vaccine Revenue 2021-2026 ($ millions)
Figure 31. Europe Intranasal Vaccine Sales 2021-2026 (K Units)
Figure 32. Europe Intranasal Vaccine Revenue 2021-2026 ($ millions)
Figure 33. Middle East & Africa Intranasal Vaccine Sales 2021-2026 (K Units)
Figure 34. Middle East & Africa Intranasal Vaccine Revenue 2021-2026 ($ millions)
Figure 35. Americas Intranasal Vaccine Sales Market Share by Country in 2026
Figure 36. Americas Intranasal Vaccine Revenue Market Share by Country (2021-2026)
Figure 37. Americas Intranasal Vaccine Sales Market Share by Type (2021-2026)
Figure 38. Americas Intranasal Vaccine Sales Market Share by Application (2021-2026)
Figure 39. United States Intranasal Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 40. Canada Intranasal Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 41. Mexico Intranasal Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 42. Brazil Intranasal Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 43. APAC Intranasal Vaccine Sales Market Share by Region in 2026
Figure 44. APAC Intranasal Vaccine Revenue Market Share by Region (2021-2026)
Figure 45. APAC Intranasal Vaccine Sales Market Share by Type (2021-2026)
Figure 46. APAC Intranasal Vaccine Sales Market Share by Application (2021-2026)
Figure 47. China Intranasal Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 48. Japan Intranasal Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 49. South Korea Intranasal Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 50. Southeast Asia Intranasal Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 51. India Intranasal Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 52. Australia Intranasal Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 53. China Taiwan Intranasal Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 54. Europe Intranasal Vaccine Sales Market Share by Country in 2026
Figure 55. Europe Intranasal Vaccine Revenue Market Share by Country (2021-2026)
Figure 56. Europe Intranasal Vaccine Sales Market Share by Type (2021-2026)
Figure 57. Europe Intranasal Vaccine Sales Market Share by Application (2021-2026)
Figure 58. Germany Intranasal Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 59. France Intranasal Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 60. UK Intranasal Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 61. Italy Intranasal Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 62. Russia Intranasal Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 63. Middle East & Africa Intranasal Vaccine Sales Market Share by Country (2021-2026)
Figure 64. Middle East & Africa Intranasal Vaccine Sales Market Share by Type (2021-2026)
Figure 65. Middle East & Africa Intranasal Vaccine Sales Market Share by Application (2021-2026)
Figure 66. Egypt Intranasal Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 67. South Africa Intranasal Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 68. Israel Intranasal Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 69. Turkey Intranasal Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 70. GCC Countries Intranasal Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 71. Manufacturing Cost Structure Analysis of Intranasal Vaccine in 2026
Figure 72. Manufacturing Process Analysis of Intranasal Vaccine
Figure 73. Industry Chain Structure of Intranasal Vaccine
Figure 74. Channels of Distribution
Figure 75. Global Intranasal Vaccine Sales Market Forecast by Region (2027-2032)
Figure 76. Global Intranasal Vaccine Revenue Market Share Forecast by Region (2027-2032)
Figure 77. Global Intranasal Vaccine Sales Market Share Forecast by Type (2027-2032)
Figure 78. Global Intranasal Vaccine Revenue Market Share Forecast by Type (2027-2032)
Figure 79. Global Intranasal Vaccine Sales Market Share Forecast by Application (2027-2032)
Figure 80. Global Intranasal Vaccine Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Intranasal Vaccine
Figure 2. Intranasal Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Intranasal Vaccine Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Intranasal Vaccine Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Intranasal Vaccine Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Intranasal Vaccine Sales Market Share by Country/Region (2025)
Figure 10. Intranasal Vaccine Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Flu Vaccine
Figure 12. Product Picture of COVID-19 Vaccines
Figure 13. Global Intranasal Vaccine Sales Market Share by Type in 2026
Figure 14. Global Intranasal Vaccine Revenue Market Share by Type (2021-2026)
Figure 15. Intranasal Vaccine Consumed in Hospital
Figure 16. Global Intranasal Vaccine Market: Hospital (2021-2026) & (K Units)
Figure 17. Intranasal Vaccine Consumed in Clinic
Figure 18. Global Intranasal Vaccine Market: Clinic (2021-2026) & (K Units)
Figure 19. Global Intranasal Vaccine Sale Market Share by Application (2025)
Figure 20. Global Intranasal Vaccine Revenue Market Share by Application in 2026
Figure 21. Intranasal Vaccine Sales by Company in 2026 (K Units)
Figure 22. Global Intranasal Vaccine Sales Market Share by Company in 2026
Figure 23. Intranasal Vaccine Revenue by Company in 2026 ($ millions)
Figure 24. Global Intranasal Vaccine Revenue Market Share by Company in 2026
Figure 25. Global Intranasal Vaccine Sales Market Share by Geographic Region (2021-2026)
Figure 26. Global Intranasal Vaccine Revenue Market Share by Geographic Region in 2026
Figure 27. Americas Intranasal Vaccine Sales 2021-2026 (K Units)
Figure 28. Americas Intranasal Vaccine Revenue 2021-2026 ($ millions)
Figure 29. APAC Intranasal Vaccine Sales 2021-2026 (K Units)
Figure 30. APAC Intranasal Vaccine Revenue 2021-2026 ($ millions)
Figure 31. Europe Intranasal Vaccine Sales 2021-2026 (K Units)
Figure 32. Europe Intranasal Vaccine Revenue 2021-2026 ($ millions)
Figure 33. Middle East & Africa Intranasal Vaccine Sales 2021-2026 (K Units)
Figure 34. Middle East & Africa Intranasal Vaccine Revenue 2021-2026 ($ millions)
Figure 35. Americas Intranasal Vaccine Sales Market Share by Country in 2026
Figure 36. Americas Intranasal Vaccine Revenue Market Share by Country (2021-2026)
Figure 37. Americas Intranasal Vaccine Sales Market Share by Type (2021-2026)
Figure 38. Americas Intranasal Vaccine Sales Market Share by Application (2021-2026)
Figure 39. United States Intranasal Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 40. Canada Intranasal Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 41. Mexico Intranasal Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 42. Brazil Intranasal Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 43. APAC Intranasal Vaccine Sales Market Share by Region in 2026
Figure 44. APAC Intranasal Vaccine Revenue Market Share by Region (2021-2026)
Figure 45. APAC Intranasal Vaccine Sales Market Share by Type (2021-2026)
Figure 46. APAC Intranasal Vaccine Sales Market Share by Application (2021-2026)
Figure 47. China Intranasal Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 48. Japan Intranasal Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 49. South Korea Intranasal Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 50. Southeast Asia Intranasal Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 51. India Intranasal Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 52. Australia Intranasal Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 53. China Taiwan Intranasal Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 54. Europe Intranasal Vaccine Sales Market Share by Country in 2026
Figure 55. Europe Intranasal Vaccine Revenue Market Share by Country (2021-2026)
Figure 56. Europe Intranasal Vaccine Sales Market Share by Type (2021-2026)
Figure 57. Europe Intranasal Vaccine Sales Market Share by Application (2021-2026)
Figure 58. Germany Intranasal Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 59. France Intranasal Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 60. UK Intranasal Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 61. Italy Intranasal Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 62. Russia Intranasal Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 63. Middle East & Africa Intranasal Vaccine Sales Market Share by Country (2021-2026)
Figure 64. Middle East & Africa Intranasal Vaccine Sales Market Share by Type (2021-2026)
Figure 65. Middle East & Africa Intranasal Vaccine Sales Market Share by Application (2021-2026)
Figure 66. Egypt Intranasal Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 67. South Africa Intranasal Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 68. Israel Intranasal Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 69. Turkey Intranasal Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 70. GCC Countries Intranasal Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 71. Manufacturing Cost Structure Analysis of Intranasal Vaccine in 2026
Figure 72. Manufacturing Process Analysis of Intranasal Vaccine
Figure 73. Industry Chain Structure of Intranasal Vaccine
Figure 74. Channels of Distribution
Figure 75. Global Intranasal Vaccine Sales Market Forecast by Region (2027-2032)
Figure 76. Global Intranasal Vaccine Revenue Market Share Forecast by Region (2027-2032)
Figure 77. Global Intranasal Vaccine Sales Market Share Forecast by Type (2027-2032)
Figure 78. Global Intranasal Vaccine Revenue Market Share Forecast by Type (2027-2032)
Figure 79. Global Intranasal Vaccine Sales Market Share Forecast by Application (2027-2032)
Figure 80. Global Intranasal Vaccine Revenue Market Share Forecast by Application (2027-2032)
